Look Kirk
Chief Financial Officer
Award
Calculated transaction value
$0
260,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Oncolytics Biotech Inc
ONCY
Transactions reported in official disclosures
14 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Look Kirk Chief Financial Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kelly Jared Chief Executive Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Andrews Patricia S Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Holtham Angela Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Glover Stephen C. Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Seizinger Bernd R. Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Parsons James T. Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hagerman Allison Chief Technology Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Aromando Andrew Chief Business Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Pisano Wayne Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Rigby Jonathan Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Mcadory John Bearden Chief Operating Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Heineman Thomas Charles Chief Medical Officer | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Brown Deborah Margaret Director | Jun 3, 2026 2-day lag | Award Jun 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Kelly Jared
Chief Executive Officer
Award
Calculated transaction value
$0
755,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Andrews Patricia S
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Holtham Angela
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Glover Stephen C.
Director
Award
Calculated transaction value
$0
96,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Seizinger Bernd R.
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Parsons James T.
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Hagerman Allison
Chief Technology Officer
Award
Calculated transaction value
$0
260,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Aromando Andrew
Chief Business Officer
Award
Calculated transaction value
$0
260,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Pisano Wayne
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Rigby Jonathan
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Mcadory John Bearden
Chief Operating Officer
Award
Calculated transaction value
$0
145,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Heineman Thomas Charles
Chief Medical Officer
Award
Calculated transaction value
$0
260,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026
Brown Deborah Margaret
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Jun 1, 2026
Filed
Jun 3, 2026